DXSZ:F:F-Xtrackers II - USD Overnight Rate Swap UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 172.368

Change

0.00 (0.00)%

Market Cap

USD 0.18B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-05 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.11 (+0.42%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.19 (+0.38%)

USD 116.66B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.19 (+0.35%)

USD 91.05B
SXR8:F iShares Core S&P 500 UCITS ETF..

+0.80 (+0.16%)

USD 85.22B
FRCJ:F UBS MSCI Japan Socially Respon..

+0.11 (+0.50%)

USD 74.74B
EUNL:F iShares Core MSCI World UCITS ..

+0.29 (+0.31%)

USD 72.04B
SXRZ:F iShares VII PLC - iShares Nikk..

-0.50 (-0.22%)

USD 55.89B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.06 (+0.42%)

USD 55.84B
VUAA:F Vanguard S&P 500 UCITS Acc

-0.27 (-0.29%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

-0.10 (-0.11%)

USD 51.63B

ETFs Containing DXSZ:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain -1.96% 24% F 47% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.96% 22% F 42% F
Trailing 5 Years  
Capital Gain 9.20% 41% F 50% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.20% 40% F 38% F
Average Annual (5 Year Horizon)  
Capital Gain 2.38% 54% F 57% F
Dividend Return 2.38% 52% F 52% F
Total Return N/A 96% N/A 99% N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.20% 67% D+ 86% B+
Risk Adjusted Return 29.03% 55% F 60% D-
Market Capitalization 0.18B 38% F 37% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.